Dengue: a continuing global threat
Open accessThe DOI matches its Crossref record; 129 of the 130 references it cites were found in a registry or an index.
Abstract
Dengue fever and dengue haemorrhagic fever are important arthropod-borne viral diseases. Each year, there are ∼50 million dengue infections and ∼500,000 individuals are hospitalized with dengue haemorrhagic fever, mainly in Southeast Asia, the Pacific and the Americas. Illness is produced by any of the four dengue virus serotypes. A global strategy aimed at increasing the capacity for surveillance and outbreak response, changing behaviours and reducing the disease burden using integrated vector management in conjunction with early and accurate diagnosis has been advocated. Antiviral drugs and vaccines that are currently under development could also make an important contribution to dengue control in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Until recent advances in vaccine development [16–17], and the approval and potential availability of the first product in 2016 [18], dengue has been unique among the major vector-borne diseases, in that prevention from infection could only be attempted by reducing or eliminating bites by infected vector mosquitoes [19, 20].”
From Is Dengue Vector Control Deficient in Effectiveness or Evidence?: Systematic Review and Meta-analysis (2016) · cites this paper as [20]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Although a vaccine could be available as early as 2016, vector control remains the primary approach used to prevent dengue, the most common and widespread arbovirus of humans worldwide.”
From Is Dengue Vector Control Deficient in Effectiveness or Evidence?: Systematic Review and Meta-analysis (2016) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dengue and Dengue Hemorrhagic Fever
Gubler, D. J. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.3.480 · Cited by 4,310
Self-citationLanciotti, R. S., Calisher, C. H., Gubler, D. J., Chang, G. J., & Vorndam, A. V. (1992) · Journal of Clinical Microbiology · doi:10.1128/jcm.30.3.545-551.1992 · Cited by 1,818 · cited 1×
“The most E u r op e P M C F und e r s A u t ho r M a nu s c r i p t s E u r op e P M C F und e r s A u t ho r M a nu s c r i p t s commonly used NAATs are based on a single RT-PCR assay 95,96 , a nested RT-PCR assay 96 or a one-step multiplex RT-PCR assay 97 .”
MethodSelf-citationDengue Viremia Titer, Antibody Response Pattern, and Virus Serotype Correlate with Disease Severity
Vaughn, D. W., Green, S., Kalayanarooj, S., Innis, B. L., Nimmannitya, S., Suntayakorn, S., Endy, T. P., Raengsakulrach, B., Rothman, A. L., Ennis, F. A., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315215 · Cited by 1,632 · cited 1×
“One advantage of this assay is the ability to determine viral titre early in dengue illness, which is believed to be an important predictor of disease severity 102 .”
BackgroundGuzmán, M. G., & Kouri, G. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(01)00171-2 · Cited by 1,163
Spectrum of Disease and Relation to Place of Exposure among Ill Returned Travelers
Freedman, D. O., Weld, L. H., Kozarsky, P. E., Fisk, T., Robins, R., von Sonnenburg, F., Keystone, J. S., Pandey, P., & Cetron, M. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051331 · Cited by 1,081
Dengue and dengue haemorrhagic fever
Rigau-Pérez, J. G., Clark, G. G., Gubler, D. J., Reiter, P., Sanders, E. J., & Vance Vorndam, A. (1998) · The Lancet · doi:10.1016/s0140-6736(97)12483-7 · Cited by 1,051
Self-citationCross-Reacting Antibodies Enhance Dengue Virus Infection in Humans
Dejnirattisai, W., Jumnainsong, A., Onsirisakul, N., Fitton, P., Vasanawathana, S., Limpitikul, W., Puttikhunt, C., Edwards, C., Duangchinda, T., Supasa, S., et al. (2010) · Science · doi:10.1126/science.1185181 · Cited by 943 · cited 1×
“The available data suggest that neutralizing antibodies are the major contributors to protective immunity 124,125 , however the role of the cellular immune response requires further study 123 .”
BackgroundCalisher, C. H., Karabatsos, N., Dalrymple, J. M., Shope, R. E., Porterfield, J. S., Westaway, E. G., & Brandt, W. E. (1989) · Journal of General Virology · doi:10.1099/0022-1317-70-1-37 · Cited by 893 · cited 1×
“These tests are mainly for research and vaccine studies 90–94 .”
BackgroundOriginal antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever
Mongkolsapaya, J., Dejnirattisai, W., Xu, X.-N., Vasanawathana, S., Tangthawornchaikul, N., Chairunsri, A., Sawasdivorn, S., Duangchinda, T., Dong, T., Rowland-Jones, S., et al. (2003) · Nature Medicine · doi:10.1038/nm887 · Cited by 821 · cited 1×
“…CD4 + and CD8 + cells that have a diminished capacity to kill but nonetheless release inflammatory cytokines that contribute to disease severity 51 ; that severe disease is caused by DENVs of increased virulence 52 ; and the suggestion that cross-reactivity between NS1 and human platelets and…”
BackgroundDengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody
Halstead, S., & O'Rourke, E. (1977) · The Journal of Experimental Medicine · doi:10.1084/jem.146.1.201 · Cited by 804 · cited 5×
“Both in vitro and in vivo , macrophages and monocytes participate in antibody-dependent enhancement (ADE) 18–20 .”
BackgroundInfluentialSelf-citation
Research works printed but not linked: 3
- Vorndam, V. & Kuno, G. In Dengue and Dengue Hemorrhagic Fever (eds Gubler, D. J. & Kuno, G.) 313–333 (CAB International, New York, USA, 1997).
- Gubler, D. J. Serologic diagnosis of dengue/dengue haemorrhagic fever. Dengue Bull. 20, 20–23 (1996).
- Singh, K. R. P. & Paul, S. D. Multiplication of arboviruses in cell lines from Aedes albopictus and Aedes aegypti. Curr. Sci. 37, 65–67 (1968).
Cited by
Items 201–300 of 1,001
Kallies, R., Kopp, A., Zirkel, F., Estrada, A., Gillespie, T. R., Drosten, C., & Junglen, S. (2014) · Viruses · doi:10.3390/v6114346 · Cited by 85
“, Yellow fever virus, Dengue virus, and Chikungunya virus [1–3].”
BackgroundReview of the Syntheses and Activities of Some Sulfur-Containing Drugs
Ferro, C. T. B., dos Santos, B. F., Silva, C. D. G., Brand, G., da Silva, C. D. G., & Domingues, N. L. C. (2020) · Current Organic Synthesis · doi:10.2174/1570179417666200212113412 · Cited by 81
The key amino acids of E protein involved in early flavivirus infection: viral entry
Hu, T., Wu, Z., Wu, S., Chen, S., & Cheng, A. (2021) · Virology Journal · doi:10.1186/s12985-021-01611-2 · Cited by 81
The Roles of IRF-3 and IRF-7 in Innate Antiviral Immunity against Dengue Virus
Chen, H., King, K., Tu, J., Sanchez, M., Luster, A. D., & Shresta, S. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300799 · Cited by 85
“5 billion people are at risk for infection in endemic areas, mainly in Southeast Asia, the Pacific, and the Americas (1).”
BackgroundInfluentialChediak, M., Pimenta, F. G., Coelho, G. E., Braga, I. A., Lima, J. B. P., Cavalcante, K. R. L. J., de Sousa, L. C., de Melo-Santos, M. A. V., Macoris, M. D. L. D. G., de Araújo, A. P., et al. (2016) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-02760150409 · Cited by 81
“This scenario prevails throughout the affected tropical and subtropical regions of the world, which roughly encompasses about half of the global population (Guzman et al. 2010).”
BackgroundCellular microRNA-miR-548g-3p modulates the replication of dengue virus
Wen, W., He, Z., Jing, Q., Hu, Y., Lin, C., Zhou, R., Wang, X., Su, Y., Yuan, J., Chen, Z., et al. (2014) · Journal of Infection · doi:10.1016/j.jinf.2014.12.001 · Cited by 84
“Annually, more than 50 million people are infected by DENV worldwide, among which 500,000 DENVinfected patients need to be hospitalized.(2) Despite an urgent need for effective counter-DENV strategies, thus far neither licensed vaccine nor specific therapeutic agent against DENV is available.”
InfluentialHuang, C. Y. ‐., Kinney, R. M., Livengood, J. A., Bolling, B. G., Arguello, J. J., Luy, B. E., Silengo, S. J., Boroughs, K. L., Stovall, J. L., Kalanidhi, A. P., et al. (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002243 · Cited by 80
“cases exhibiting hemorrhagic manifestations [1,2].”
Garlic Organosulfur Compounds Reduce Inflammation and Oxidative Stress during Dengue Virus Infection
Hall, A., Troupin, A., Londono-Renteria, B. L., & Colpitts, T. M. (2017) · Viruses · doi:10.3390/v9060159 · Cited by 87
Aziz, A. T., Al‐Shami, S. A., Mahyoub, J. A., Hatabbi, M., Ahmad, A. H., & Rawi, C. S. M. (2014) · Parasites & Vectors · doi:10.1186/1756-3305-7-258 · Cited by 79
“Although there is likelihood of outbreak and spread of dengue in epidemic proportions and rise of its vector populations, relatively less attention is paid on updates concerning the outbreaks and epidemiology of dengue in the Middle East, especially in Saudi Arabia and Yemen [3].”
BackgroundThe RNAi pathway plays a small part in Wolbachia-mediated blocking of dengue virus in mosquito cells
Terradas, G., Joubert, D. A., & McGraw, E. A. (2017) · Scientific Reports · doi:10.1038/srep43847 · Cited by 85
Trends of Dengue Disease Epidemiology
Cucunawangsih, C., & Lugito, N. P. H. (2017) · Virology Research and Treatment · doi:10.1177/1178122x17695836 · Cited by 79
Allard, P., Dâu, E. T. H., Eydoux, C., Guillemot, J., Dumontet, V., Poullain, C., Canard, B., Guéritte, F., & Litaudon, M. (2011) · Journal of Natural Products · doi:10.1021/np200715v · Cited by 79
A Critique of the Dopamine Hypothesis of Schizophrenia and Psychosis
Moncrieff, J. (2009) · Harvard Review of Psychiatry · doi:10.1080/10673220902979896 · Cited by 77
Symptomatic Dengue Infection during Pregnancy and Infant Outcomes: A Retrospective Cohort Study
Friedman, E. E., Dallah, F., Harville, E. W., Myers, L., Buekens, P. M., Bréart, G., & Carles, G. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003226 · Cited by 84
“Approximately 390 million dengue virus infections occur each year, and about 500,000 of these require hospitalization [1,2].”
BackgroundCharacterization of the activity of 2′-C-methylcytidine against dengue virus replication
Lee, J., Tseng, C.-K., Wu, Y., Kaushik‐Basu, N., Lin, C., Chen, W., & Wu, H. (2015) · Antiviral Research · doi:10.1016/j.antiviral.2015.01.002 · Cited by 78
A brief review on dengue molecular virology, diagnosis, treatment and prevalence in Pakistan
Idrees, S., & Ashfaq, U. A. (2012) · Genetic Vaccines and Therapy · doi:10.1186/1479-0556-10-6 · Cited by 78
“Dengue virus (DENV) infection is an important arthropod-born viral infection infecting about 2.5 billion people worldwide, of which approximately 975 million belong to large and small cities of tropical and subtropical countries in Southeast Asia, the Pacific and the America [1, 2].”
BackgroundInfluentialDengue-associated acute kidney injury
Oliveira, J. F. P., & Burdmann, E. A. (2015) · Clinical Kidney Journal · doi:10.1093/ckj/sfv106 · Cited by 78
Xu, S., Li, H., Shao, X., Fan, C., Ericksen, B., Liu, J., Chi, C., & Wang, C. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300655h · Cited by 78
A new lineage nomenclature to aid genomic surveillance of dengue virus
Hill, V., Cleemput, S., Pereira, J. S., Gifford, R. J., Fonseca, V., Tegally, H., Brito, A. F., Ribeiro, G. D. C., de Souza, V. C., Brcko, I. C., et al. (2024) · PLoS Biology · doi:10.1371/journal.pbio.3002834 · Cited by 85
“The GLUE framework is an open software environment for managing and analyzing virus sequence data [42].”
InfluentialNougaırède, A., de Fabritus, L., Aubry, F., Gould, E. A., Holmes, E. C., & de Lamballerie, X. N. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003172 · Cited by 83
“The major outbreaks of dengue fever [1], West Nile encephalitis [2], Chikungunya fever [3], and Rift Valley fever [4]”
BackgroundDengue in the United States of America: A Worsening Scenario?
Áñez, G., & Rios, M. (2013) · BioMed Research International · doi:10.1155/2013/678645 · Cited by 87
“Hindawi Publishing Corporation BioMed Research International Volume 2013, Article ID 678645, 13 pages http://dx.doi.org/10.1155/2013/678645”
InfluentialAnti-viral triterpenes: a review
Darshani, P., Sarma, S. S., Srivastava, A. K., Baishya, R., & Kumar, D. (2022) · Phytochemistry Reviews · doi:10.1007/s11101-022-09808-1 · Cited by 82
“Hence, the development of a safe and effective anti-DENV agent is required to reduce the mortality and morbidity burden of the infection (Guzman et al. 2010; Tuiskunen and Lundkvist 2013).”
BackgroundGupta, G., Khan, S., Guleria, V., Almjally, A., Alabduallah, B. I., Siddiqui, T., Albahlal, B. M., Alajlan, S. A., & Alsubaie, M. N. (2023) · Diagnostics · doi:10.3390/diagnostics13061093 · Cited by 76
“5 billion people who live in dengue-endemic areas [4], with an annual infection rate of 400 million individuals and a mortality rate that can vary from 5 to 20 percent in specific locations [5].”
BackgroundDjamiatun, K., van der Ven, A. J. A. M., de Groot, P. G., Faradz, S. M., Hapsari, D. O., Dolmans, W. M. V., Sebastian, S. A. E., Fijnheer, R., & de Mast, Q. (2012) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001628 · Cited by 76
“It usually manifests as a non-specific febrile illness, but its course may become complicated by bleeding and a transient plasma leakage that may ultimately lead to shock and death [1].”
BackgroundHuman Apolipoprotein A-I Is Associated with Dengue Virus and Enhances Virus Infection through SR-BI
Li, Y., Kakinami, C., Li, Q., Yang, B., & Li, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070390 · Cited by 77
“Disease symptoms are ranged from mild fever to severe forms of illness, dengue hemorrhagic fever (DHS) and dengue shock syndrome (DSS), which account for tens of thousands deaths primarily in school-age children [1,2].”
BackgroundHonokiol, a Lignan Biphenol Derived from the Magnolia Tree, Inhibits Dengue Virus Type 2 Infection
Fang, C., Chen, S.-J., Wu, H., Ping, Y., Lin, C.-Y., Shiuan, D., Chen, C., Lee, Y., & Huang, K. (2015) · Viruses · doi:10.3390/v7092852 · Cited by 76
“Infection with DENV leads to approximately 500,000 severe life-threatening cases and over 20,000 deaths every year [44].”
BackgroundQuantification of NS1 dengue biomarker in serum via optomagnetic nanocluster detection
Antunes, P., Watterson, D., Parmvi, M., Burger, R., Boisen, A., Young, P. R., Cooper, M. A., Hansen, M. F., Ranzoni, A., & Donolato, M. (2015) · Scientific Reports · doi:10.1038/srep16145 · Cited by 81
Zhou, Y., Liu, Y., Yan, H., Li, Y., Zhang, H., Xu, J., Puthiyakunnon, S., & Chen, X. (2014) · Parasites & Vectors · doi:10.1186/preaccept-9439423921281212 · Cited by 85
Identification of Novel Natural Products as Effective and Broad-Spectrum Anti-Zika Virus Inhibitors
Gao, Y., Tai, W., Wang, N., Li, X. O., Jiang, S., Debnath, A. K., Du, L., & Chen, S. (2019) · Viruses · doi:10.3390/v11111019 · Cited by 82
“Four antigenic serotypes of DENV (DENV-1–4) lead to dengue disease (dengue fever, dengue hemorrhagic fever, or dengue shock syndrome), with cases increasing annually [13,14].”
BackgroundYan, J., Kibech, R., & Stone, C. (2021) · Frontiers in Zoology · doi:10.1186/s12983-021-00395-z · Cited by 87
Repurposing of Prochlorperazine for Use Against Dengue Virus Infection
Simanjuntak, Y., Liang, J., Lee, Y.-L., & Lin, Y. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu377 · Cited by 78
“of a DENV vaccine has been hampered in part because of the complexity of the 4 serotypes (DENV-1–4) and the potential involvement of antibody-dependent enhancement in severe dengue [1, 9].”
BackgroundBalinsky, C. A., Schmeisser, H., Wells, A. I., Ganesan, S., Jin, T., Singh, K., & Zoon, K. C. (2017) · Journal of Virology · doi:10.1128/jvi.01606-16 · Cited by 82
“Dengue virus infects an estimated 390 million people each year, with more than 2.5 billion people living in regions where they are at risk of dengue virus transmission (1) (2) (3) (4) .”
InfluentialGonçalves, C. M., de Melo, F. F., Bezerra, J. M., Chaves, B. A., Silva, B. D. M., Silva, L. D., Pessanha, J. E., Arias, J. R., Secundino, N. F. C., Norris, D. E., et al. (2014) · Parasites & Vectors · doi:10.1186/1756-3305-7-320 · Cited by 74
“Moreover, a geographic expansion of active dengue transmission has been observed over this same time period [1,2].”
BackgroundReservoirs and vectors of emerging viruses
Mackenzie, J. S., & Jeggo, M. H. (2013) · Current Opinion in Virology · doi:10.1016/j.coviro.2013.02.002 · Cited by 82
“The geographical areas in which dengue transmission occurs have expanded in recent years, and all four dengue virus serotypes are now circulating widely in Asia, Africa and the Americas [116 ] .”
Essential role of RIG-I in the activation of endothelial cells by dengue virus
Conceição, T. M., Rust, N. M., Berbel, A. C. E. R., Martins, N. B., Santos, C. A. D. N., Poian, A. T. D., & de Arruda, L. B. (2012) · Virology · doi:10.1016/j.virol.2012.09.038 · Cited by 78
Current progress in dengue vaccines
Wan, S.-W., Lin, C., Wang, S., Chen, Y., Yeh, T., Liu, H., Anderson, R., & Lin, Y.-S. (2013) · Journal of Biomedical Science · doi:10.1186/1423-0127-20-37 · Cited by 73
“; licensee BioMed Central Lt Commons Attribution License (http://creativec reproduction in any medium, provided the or occur globally with around 500,000 cases of severe dengue and 20,000 deaths per year [2].”
Dengue in the elderly: a review
Kline, S., Lee, T. H., & Leo, Y. (2017) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2017.1358610 · Cited by 79
Alves, M. J., Fernandes, P. L. T. R., Amaro, F., Osório, H. C., Luz, T. E. B., Parreira, P., de Andrade, G. L., Zé‐Zé, L., & Zeller, H. G. (2013) · Eurosurveillance · doi:10.2807/ese.18.06.20398-en · Cited by 73
“The circulation of the four serotypes of dengue in the Caribbean region and South America is described [8].”
BackgroundLanata, C. F., Andrade, T., Gil, A. I., Terrones, C., Valladolid, O., Zambrano, B., Saville, M. K., & Crevat, D. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.07.043 · Cited by 73
The Multifaceted Roles of Autophagy in Flavivirus-Host Interactions
Ke, P. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123940 · Cited by 81
“DHF, a severe dengue symptom that often results from homologous reinfection or secondary infection by a different DENV serotype, is characterized by thrombocytopenia, liver injury and hemorrhagic manifestations that ultimately induce DSS, which may cause mortality [298] [299] [300] .”
BackgroundA database of circadian and diel rhythmic gene expression in the yellow fever mosquito Aedes aegypti
Leming, M. T., Rund, S. S., Behura, S. K., Duffield, G. E., & O’Tousa, J. E. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-1128 · Cited by 73
“These infections not only cause morbidity and further economic burden in predominantly low-income countries, but also result in a substantial death toll worldwide [1-3].”
Brewoo, J. N., Kinney, R. M., Powell, T. D., Arguello, J. J., Silengo, S. J., Partidos, C. D., Huang, C. Y. ‐., Stinchcomb, D. T., & Osorio, J. E. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.11.072 · Cited by 72
“Following reinfection with the same DENV serotype, the humoral immune response has broader specificity and the antibodies are cross-reactive with other DENV serotypes since they are structurally related [6].”
InfluentialWan, S.-W., Lu, Y., Huang, C.-H., Lin, C., Anderson, R., Liu, H., Yeh, T., Yen, Y.-T., Wu‐Hsieh, B. A., & Lin, Y.-S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092495 · Cited by 72
“The major clinical manifestations of DHF/DSS are thrombocytopenia and vascular leakage, although additional symptoms, such as liver damage, may occur [1-4].”
BackgroundNull models for community detection in spatially embedded, temporal networks
Sarzynska, M., Leicht, E. A., Chowell, G., & Porter, M. A. (2015) · Journal of Complex Networks · doi:10.1093/comnet/cnv027 · Cited by 90
Mweya, C. N., Kimera, S. I., Stanley, G., Misinzo, G., & Mboera, L. E. G. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162649 · Cited by 89
“Introduction Dengue is the most important arboviral infection in the world [1,2].”
BackgroundLee, S. H., Nam, K. W., Jeong, J. Y., Yoo, S. J., Koh, Y. S., Lee, S., Heo, S. T., Seong, S., & Lee, K. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068512 · Cited by 74
“albopictus, and dengue transmission has been extending steadily toward East Asia [8,9,18,23] and is expected to expand to Korea, especially Jeju-Island and Japan, by the effects of increased international travel and climate change.”
BackgroundInfluentialFahri, S., Yohan, B., Trimarsanto, H., Sayono, S., Hadisaputro, S., Dharmana, E., Syafruddin, D., & Sasmono, R. T. (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002354 · Cited by 71
“7 kb singlestranded positive-sense RNA genome encoding 3 structural (C, prM/M, E) and 7 non-structural (NS1, NS2A, NS2B, NS3, NS4A, NS4B, NS5) proteins [3].”
Severe Dengue Fever Outbreak in Taiwan
Wang, S., Wang, W., Chang, K., Chen, Y., Tseng, S., Yen, C., Wu, D., & Chen, Y. A. (2015) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.15-0422 · Cited by 71
“Epidemiologic and immunologic studies have revealed that dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS) occur when individuals have secondary infections with heterotypic DENVs.1 In this outbreak, there were 136 cases of DHF, of which 20 resulted in death.”
BackgroundInfluentialEndothelial dysfunction in dengue virus pathology
Vervaeke, P., Vermeire, K., & Liekens, S. (2014) · Reviews in Medical Virology · doi:10.1002/rmv.1818 · Cited by 70
“DENV has a positive-sense single-stranded RNA genome of approximately 11kb that encodes three structural proteins, including the capsid (C), premembrane (prM) and envelope (E) protein and seven nonstructural (NS) proteins, NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5 [2].”
BackgroundInfluentialRupp, R. E., Luckasen, G. J., Kirstein, J. L., Osorio, J. E., Santangelo, J. D., Raanan, M. G., Smith, M. K., Wallace, D., Gordon, G. S., & Stinchcomb, D. T. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.09.008 · Cited by 70
Preclinical and clinical development of a dengue recombinant subunit vaccine
Manoff, S. B., George, S. L., Bett, A. J., Yelmene, M. L., Govindarajan, D., Eggemeyer, L. M., Sausser, M., Dubey, S. A., Casimiro, D. R., Clements, D. E., et al. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.09.101 · Cited by 70
Williams, M., Mayer, S. V., Johnson, W. L., Chen, R., Volkova, E., Vilcarromero, S., Widen, S. G., Wood, T. G., Suárez, L. A., Long, K. C., et al. (2014) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.13-0600 · Cited by 70
Aedes aegypti ML and Niemann-Pick type C family members are agonists of dengue virus infection
Jupatanakul, N., Sim, S., & Dimopoulos, G. (2013) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2013.10.002 · Cited by 70
“matic increase in dengue incidence in recent decades has resulted from an increased global prevalence of its primary vector, Aedes aegypti, along with its secondary vector, Aedes albopictus (Guzman et al., 2010; Whitehead et al., 2007).”
BackgroundFigueiredo, A., Vieira, N. C. S., dos Santos, J. F., Janegitz, B. C., Aoki, S. M., Paulo, P. S., Lovato, R. L., Nogueira, M. L., Zucolotto, V., & Guimarães, F. E. G. (2015) · Scientific Reports · doi:10.1038/srep07865 · Cited by 70
Gustatory receptor expression in the labella and tarsi of Aedes aegypti
Sparks, J. T., Vinyard, B. T., & Dickens, J. C. (2013) · Insect Biochemistry and Molecular Biology · doi:10.1016/j.ibmb.2013.10.005 · Cited by 74
“aegypti infect between 50 and 390 million people yearly through blood-meal mediated viral transmission (Guzman et al., 2010; Beatty et al., 2011; Bhatt et al., 2013).”
BackgroundThe Effect of Temperature on Wolbachia-Mediated Dengue Virus Blocking in Aedes aegypti
Ye, Y. H., Carrasco, A. M., Dong, Y., Sgrò, C. M., & McGraw, E. A. (2016) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.15-0801 · Cited by 75
Circulating dengue virus serotypes in Bangladesh from 2013 to 2016
Muraduzzaman, A. K. M., Alam, A. N., Sultana, S., Siddiqua, M., Khan, M. H., Akram, A., Haque, F., Flora, M. S., & Shirin, T. (2018) · VirusDisease · doi:10.1007/s13337-018-0469-x · Cited by 70
Dengue virus capsid protein interacts specifically with very low-density lipoproteins
Faustino, A. F., Carvalho, F. A., Martins, I. C., Castanho, M. A. R. B., Mohana‐Borges, R., Almeida, F. C. L., Poian, A. T. D., & Santos, N. C. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.06.004 · Cited by 70
“Once infected, no vaccine or specific treatments are currently available.(2,8,9) It is thus easy to imagine the extent and social impact of these outbreaks.”
BackgroundInfluentialThe interaction between claudin-1 and dengue viral prM/M protein for its entry
Che, P., Tang, H., & Li, Q. (2013) · Virology · doi:10.1016/j.virol.2013.08.009 · Cited by 69
“In the past two decades, all four serotypes DENV extended their distribution geographically and circulated around tropical and subtropical countries, including those in Southeast Asia, the Pacific, Africa, Eastern Mediterranean and the Americas (Guzman et al., 2010).”
BackgroundVoge, N. V., Perera, R. M., Mahapatra, S., Gresh, L., Balmaseda, Á., Loroño-Pino, M. A., Hopf-Jannasch, A. S., Belisle, J. T., Harris, E., Blair, C. D., et al. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004449 · Cited by 78
“Epidemic dengue fever (DF) and dengue hemorrhagic fever/dengue shock syndrome (DHF/ DSS) have emerged throughout the tropical and subtropical world with devastating consequences and are overwhelming public health capacity for diagnosis and patient care [1, 2].”
BackgroundAnalysis of significant factors for dengue fever incidence prediction
Siriyasatien, P., Phumee, A., Ongruk, P., Jampachaisri, K., & Kesorn, K. (2016) · BMC Bioinformatics · doi:10.1186/s12859-016-1034-5 · Cited by 69
“Approximately 10–15 % of infected patients are symptomatic, with ~500,000 hospitalizations annually involving the severe form of the disease [6].”
BackgroundA new era of uveitis: impact of polymerase chain reaction in intraocular inflammatory diseases
Mochizuki, M., Sugita, S., Kamoi, K., & Takase, H. (2016) · Japanese Journal of Ophthalmology · doi:10.1007/s10384-016-0474-9 · Cited by 70
“cation tests such as RT-PCR and real-time PCR [102].”
MethodDengue Virus and Its Inhibitors: A Brief Review
Tian, Y., Zhou, Y., Takagi, T., Kameoka, M., & Kawashita, N. (2018) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c17-00794 · Cited by 69
Dengue Virus M Protein Promotes NLRP3 Inflammasome Activation To Induce Vascular Leakage in Mice
Pan, P., Qi, Z., Liu, W., Wang, W., Lao, Z., Zhang, W., Shen, M., Wan, P., Xiao, F., Liu, F., et al. (2019) · Journal of Virology · doi:10.1128/jvi.00996-19 · Cited by 81
“DENV infection causes diseases ranging from self-limited DF to severe DHF and DSS (4).”
BackgroundInfluentialChu, H., George, S. L., Stinchcomb, D. T., Osorio, J. E., & Partidos, C. D. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv258 · Cited by 68
“lic health mainly in tropical and subtropical regions of the world [1, 2].”
BackgroundAssociation between nutritional status and dengue infection: a systematic review and meta-analysis
Trang, N. T. H., Long, N. P., Hue, T. T. M., Hung, L. P., Trung, T. Đ., Dinh, D. N., Luận, N. T., Huy, N. T., & Hirayama, K. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1498-y · Cited by 71
“Discussion It was thought that malnutrition is a protective factor against DSS, due to immune dysfunction [27–29].”
BackgroundLarvicidal and Repellent Activity of Mentha arvensis L. Essential Oil against Aedes aegypti
Manh, H. D., & Tuyet, O. T. (2020) · Insects · doi:10.3390/insects11030198 · Cited by 71
“There are millions of infections that occur every year in the world [1,2].”
BackgroundLyn kinase regulates egress of flaviviruses in autophagosome-derived organelles
Li, M. Y., Naik, T. S., Siu, L. Y.-L., Acuto, O., Spooner, E., Wang, P., Yang, X., Lin, Y., Bruzzone, R., Ashour, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19028-w · Cited by 67
Impact of sars-cov-2 interventions on dengue transmission
Lim, J. T., Dickens, B. S. L., Chew, L. Z. X., Choo, E. L. W., Koo, J. R., Aik, J., Ng, L. C., & Cook, A. R. (2020) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0008719 · Cited by 74
Electrochemical aptasensor for NS1 detection: Towards a fast dengue biosensor
Bachour, B., Sawazaki, M. R. B., Pereira, A. S., Russo, E. M. D. S., & Mulato, M. (2021) · Talanta · doi:10.1016/j.talanta.2021.122527 · Cited by 68
The Role of NS1 Protein in the Diagnosis of Flavivirus Infections
Fisher, R., Lustig, Y., Sklan, E. H., & Schwartz, E. (2023) · Viruses · doi:10.3390/v15020572 · Cited by 67
Wu, N., Gao, N., Fan, D., Wei, J., Zhang, J., & An, J. (2014) · Microbes and Infection · doi:10.1016/j.micinf.2014.08.011 · Cited by 68
“Although almost half of the world's population is at risk for dengue infection, there is a lack of licensed vaccines and specific anti-viral therapies against dengue disease [1, 2] .”
BackgroundLai, C.-Y., Williams, K. L., Wu, Y.-C., Knight, S., Balmaseda, Á., Harris, E., & Wang, W. (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002451 · Cited by 66
“The clinical presentation after DENV infection ranges from asymptomatic infection to a self-limited illness, dengue fever (DF), to severe and potentially life-threatening disease, dengue hemorrhagic fever/ dengue shock syndrome (DHF/DSS) [1,2].”
BackgroundInfluentialPerspective on Diagnostics for Global Health
Fu, E. S., Yager, P., Floriano, P. N., Christodoulides, N. J., & McDevitt, J. T. (2011) · IEEE Pulse · doi:10.1109/mpul.2011.942766 · Cited by 78
Iranpour, M., Moghadam, A. R., Yazdi, M., Ande, S. R., Alizadeh, J., Wiechec, E., Lindsay, R., Drebot, M., Coombs, K. M., & Ghavami, S. (2016) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2015.19 · Cited by 67
Olliaro, P., Fouque, F., Kroeger, A., Bowman, L., Velayudhan, R., Santelli, A. C. F. S., Garcia, D., Skewes-Ramm, R., Sulaiman, L. H., Tejeda, G. S., et al. (2018) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005967 · Cited by 80
Self-citationKabir, K. E., Choudhary, M. I., Ahmed, S., & Tariq, R. M. (2013) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2012.12.028 · Cited by 65
Genetic Diversity of Brazilian Aedes aegypti: Patterns following an Eradication Program
Monteiro, F. A., Schama, R., Martins, A. J., Gloria‐Soria, A., Brown, J. E. H., & Powell, J. R. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003167 · Cited by 79
“Due to the lack of an effective vaccine, currently, dengue control programs rely almost exclusively on vector control efforts [3,9].”
BackgroundAllonso, D., de Meneses, M. D. F., Fernandes, C. A., Ferreira, D. F., & Mohana‐Borges, R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113634 · Cited by 65
“The best result was achieved when anti-NS1 antibodies from DENV2 and DENV4 were combined for both steps of the sandwich procedure.”
BackgroundResultInfluentialTharakaraman, K., Robinson, L. N., Hatas, A., Chen, Y., Siyue, L., Raguram, S., Sasisekharan, V., Wogan, G. N., & Sasisekharan, R. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303645110 · Cited by 65
“More than 200 million infections of dengue virus (DV) are estimated to occur globally each year (7).”
BackgroundInterferon lambda inhibits dengue virus replication in epithelial cells
Palma-Ocampo, H. K., Flores-Alonso, J. C., Vallejo‐Ruiz, V., Reyes‐Leyva, J., Flores-Mendoza, L. K., Camacho, I. H., Rosas-Murrieta, N. H., & Santos‐López, G. (2015) · Virology Journal · doi:10.1186/s12985-015-0383-4 · Cited by 65
“This leads to half a million hospitalizations and 25,000 deaths, mainly in children [2].”
BackgroundKumar, S., Bhushan, P., Krishna, V. N., & Bhattacharya, S. (2018) · Biomicrofluidics · doi:10.1063/1.5035113 · Cited by 65
The First Outbreak of Dengue Fever in Greater Darfur, Western Sudan
Ahmed, A., Elduma, A. H., Magboul, B. A. A., Higazi, T. B., & Ali, Y. (2019) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed4010043 · Cited by 65
Taraxacum officinale and Urtica dioica extracts inhibit dengue virus serotype 2 replication in vitro
Flores-Ocelotl, M. D. R., Rosas-Murrieta, N. H., Moreno, D. A., Vallejo‐Ruiz, V., Reyes‐Leyva, J., Domínguez, F., & Santos‐López, G. (2018) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-018-2163-3 · Cited by 64
“The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. fever (DF) and more severe manifestations like dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS) [1].”
BackgroundInfluentialBetulinic acid exhibits antiviral effects against dengue virus infection
Loe, M. W. C., Hao, E., Chen, M., Li, C., Lee, R. C. H., Zhu, I. X. Y., Teo, Z. Y., Chin, W.-X., Hou, X., Deng, J., et al. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2020.104954 · Cited by 64
A small-molecule inhibitor of deubiquitinating enzyme USP14 inhibits Dengue virus replication
Nag, D. K., & Finley, D. J. (2012) · Virus Research · doi:10.1016/j.virusres.2012.01.009 · Cited by 71
Dengue in Bali: Clinical characteristics and genetic diversity of circulating dengue viruses
Megawati, D., Masyeni, S., Yohan, B., Lestarini, A., Hayati, R., Meutiawati, F., Suryana, K., Widarsa, T., Budiyasa, D. G. A., Budiyasa, N., et al. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005483 · Cited by 64
Glycyrrhizic acid derivatives as Dengue virus inhibitors
Балтина, Л. А., Tasi, Y.-T., Huang, S.-H., Lai, H., Baltina, L. A., Petrova, S. F., Yunusov, M. S., & Lin, C. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.126645 · Cited by 64
“DENV reemerges in recent years and poses a threat to the health of the population of more than 100 countries around the world, as considered one of the greatest virus threats to mankind.(1,2) Over the past 50 years, the incidence of Dengue fever has increased 30-fold as a result of its expansion into new countries.”
BackgroundBhatnagar, P., Sreekanth, G. P., Murali‐Krishna, K., Chandele, A., & Sitaraman, R. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.574067 · Cited by 69
“Dengue is a global epidemic resulting in over 100 million clinical cases globally each year with symptoms ranging from fever to hemorrhage and/or shock that can be fatal, especially among children (Guzman et al., 2010; Bhatt et al., 2013).”
BackgroundShort‐term suppression of Aedes aegypti using genetic control does not facilitate Aedes albopictus
Gorman, K. J., Young, J., Pineda, L., Márquez, R., Sosa, N. R., Bernal, D., Torres, R., Soto, Y., Lacroix, R., Naish, N., et al. (2015) · Pest Management Science · doi:10.1002/ps.4151 · Cited by 75
Raut, R., Beesetti, H., Tyagi, P., Khanna, I., Jain, S. K., Jeankumar, V. U., Yogeeswari, P., Sriram, D., & Swaminathan, S. (2015) · Virology Journal · doi:10.1186/s12985-015-0248-x · Cited by 70
“This is because, each of the four DENVs can cause the full spectrum of dengue disease, and all four DENV serotypes tend to co-circulate in hyperendemic regions [2,3].”
BackgroundSpatiotemporal analysis of dengue fever in Nepal from 2010 to 2014
Acharya, B. K., Cao, C., Lakes, T., Chen, W., & Naeem, S. (2016) · BMC Public Health · doi:10.1186/s12889-016-3432-z · Cited by 63
“The Aedes aegypti mosquito which is the main vector of dengue, lives in urban habitats and breeds mostly in man-made containers [7, 8].”
Backgroundda Costa, C. F., da Silva, A. V., do Nascimento, V. A., de Souza, V. C., Monteiro, D. C. D. S., Terrazas, W. C. M., dos Passos, R. A., Nascimento, S., Lima, J. B. P., & Naveca, F. G. (2018) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006594 · Cited by 63
Bara, J. J., Rapti, Z., Cáceres, C. E., & Muturi, E. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126703 · Cited by 65
“5 [53, 54] Extrinsic Incubation Period (n) 6–12 days [4, 9, 12] Vector competence (b) -”
BackgroundInfluentialMichels, M., Sumardi, U., de Mast, Q., Jusuf, H., Puspita, M., Dewi, I. M. W., Sinarta, S., Alisjahbana, B., & van der Ven, A. J. A. M. (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002277 · Cited by 61
“Transient plasma leakage into serosal cavities, which may progress to life-threatening hypovolemic shock, is a hallmark of severe dengue [1,2].”
BackgroundCost-effectiveness of Novel System of Mosquito Surveillance and Control, Brazil
Pepin, K. M., Marques-Toledo, C., Scherrer, L. R., Morais, M. M., Ellis, B. R., & Eiras, Á. E. (2013) · Emerging infectious diseases · doi:10.3201/eid1904.120117 · Cited by 63
“D viruses cause ≈50 million infections annually worldwide, and ≈1% of these infections require hospitalization because of dengue hemorrhagic fever (1).”
BackgroundDengue Virus Infection of Aedes aegypti Requires a Putative Cysteine Rich Venom Protein
Londono-Renteria, B. L., Troupin, A., Conway, M. J., Vesely, D., Ledizet, M., Roundy, C. M., Cloherty, E., Jameson, S. B., Vanlandingham, D. L., Higgs, S., et al. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005202 · Cited by 61
“There are no specific antivirals or approved vaccines for use in DENV treatment or prevention [4,7–9].”
BackgroundHu, S., Li, M., Zhong, L., Lu, S.-M., Liu, Z.-X., Pu, J., Wen, J., & Huang, X. (2015) · BMC Microbiology · doi:10.1186/s12866-015-0595-1 · Cited by 61
“DENV infection causes dengue fever, the more dangerous dengue hemorrhagic fever and dengue shock syndrome, all of which are very contagious [3].”
BackgroundProtein Interactions during the Flavivirus and Hepacivirus Life Cycle
Gerold, G., Bruening, J., Weigel, B., & Pietschmann, T. (2017) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r116.065649 · Cited by 70
A Review on Epidemiology of Dengue Viral Infection as an Emerging Disease
Dehghani, R., & Kassiri, H. (2021) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2021.00406 · Cited by 60
Metadata
- Authors
- Guzman, M. G., Halstead, S. B., Artsob, H., Buchy, P., Farrar, J., Gubler, D. J., Hunsperger, E., Kroeger, A., Margolis, H. S., Martínez, E., Nathan, M. B., Pelegrino, J. L., Simmons, C., Yoksan, S., & Peeling, R. W.
- Affiliations
- Public Health Agency of Canada (CA)
- Institut Pasteur du Cambodge (KH)
- Oxford University Clinical Research Unit (VN)
- National University of Singapore (SG)
- Centers for Disease Control and Prevention (US)
- World Bank (US)
- Instituto de Medicina Tropical “Pedro Kourí” (CU)
- World Health Organization (CH)
- Mahidol University (TH)
- Corresponding author
- Peeling, Rosanna W.
- ORCID
- Venue
- Nature Reviews Microbiology
- Published
- 2010-12
- Volume
- 8
- Issue
- S12
- Pages
- S7-S16
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- PMC
- PMC4333201
- OpenAlex
- W2042479028
- Cited by
- 2,082
- References
- 130
- Citations by year
- 2026: 68 · 2025: 104 · 2024: 94 · 2023: 135 · 2022: 116 · 2021: 133 · 2020: 140 · 2019: 127 · 2018: 142 · 2017: 151 · 2016: 163 · 2015: 189 · 2014: 186 · 2013: 161 · 2012: 132
- FWCI
- 15.35
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Microbiology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Minerva Access (University of Melbourne) (submittedVersion)
- Funders
- Wellcome Trust (084368)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Mosquito-borne diseases and control
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Dengue and Mosquito Control Research
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Vectors
- Keywords
- dengue, dengue hemorrhagic fever, arboviruses, dengue serotypes, vector-borne diseases, dengue surveillance, outbreak response, integrated vector management, early diagnosis, dengue vaccine, antiviral agents, dengue control
- MeSH terms
- Americas, Asia, Southeastern, Dengue, Dengue Virus, Hospitalization, Humans, Insect Control, Pacific Islands
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.